W Król

1.9k total citations
22 papers, 1.3k citations indexed

About

W Król is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, W Król has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in W Król's work include Statistical Methods in Clinical Trials (4 papers), Gastroesophageal reflux and treatments (3 papers) and Intraocular Surgery and Lenses (3 papers). W Król is often cited by papers focused on Statistical Methods in Clinical Trials (4 papers), Gastroesophageal reflux and treatments (3 papers) and Intraocular Surgery and Lenses (3 papers). W Król collaborates with scholars based in United States, United Kingdom and Israel. W Król's co-authors include Robert A. Rosenheck, Joyce A. Cramer, Gail F. Kirk, John Krystal, Joseph F. Collins, William O. Williford, Stuart J. Spechler, Gail Kirk, John H. Krystal and Barry M. Massie and has published in prestigious journals such as New England Journal of Medicine, Circulation and Gastroenterology.

In The Last Decade

W Król

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Król United States 12 409 370 241 192 172 22 1.3k
Herbert R. Karp United States 15 333 0.8× 339 0.9× 118 0.5× 81 0.4× 426 2.5× 17 1.1k
Michael Gibbs United States 19 181 0.4× 229 0.6× 295 1.2× 90 0.5× 405 2.4× 84 1.5k
Gary T.C. Ko Hong Kong 25 315 0.8× 172 0.5× 412 1.7× 27 0.1× 109 0.6× 66 1.5k
G. O’Sullivan United Kingdom 23 72 0.2× 752 2.0× 1.3k 5.4× 75 0.4× 138 0.8× 74 2.0k
E. A. M. Gale United Kingdom 20 241 0.6× 218 0.6× 608 2.5× 22 0.1× 68 0.4× 27 2.2k
Minkyung Oh South Korea 19 111 0.3× 113 0.3× 319 1.3× 48 0.3× 120 0.7× 94 1.2k
Jingpu Shi China 20 244 0.6× 270 0.7× 102 0.4× 23 0.1× 155 0.9× 63 1.2k
Niels Zeuthen Denmark 6 224 0.5× 225 0.6× 626 2.6× 104 0.5× 112 0.7× 17 2.7k
Vernice Bates United States 18 856 2.1× 188 0.5× 167 0.7× 134 0.7× 382 2.2× 38 1.6k
Chien‐Chou Su Taiwan 11 200 0.5× 157 0.4× 161 0.7× 36 0.2× 113 0.7× 42 1.2k

Countries citing papers authored by W Król

Since Specialization
Citations

This map shows the geographic impact of W Król's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Król with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Król more than expected).

Fields of papers citing papers by W Król

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Król. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Król. The network helps show where W Król may publish in the future.

Co-authorship network of co-authors of W Król

This figure shows the co-authorship network connecting the top 25 collaborators of W Król. A scholar is included among the top collaborators of W Król based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Król. W Król is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massie, Barry M., Joseph F. Collins, Susan E. Ammon, et al.. (2009). Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure. Circulation. 119(12). 1616–1624. 260 indexed citations
2.
Collins, Joseph F., Ronald N. Gaster, & W Król. (2005). Outcomes in Patients Having Vitreous Presentation During Cataract Surgery Who Lack Capsular Support for a Nonsutured PC IOL. American Journal of Ophthalmology. 141(1). 71–78.e1. 4 indexed citations
3.
Collins, Joseph F., W Król, Gail F. Kirk, & Ronald N. Gaster. (2004). The effect of vitreous presentation during extracapsular cataract surgery on the postoperative visual acuity at one year. American Journal of Ophthalmology. 138(4). 536–542. 7 indexed citations
4.
Massie, Barry M., W Król, Susan E. Ammon, et al.. (2004). The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics. Journal of Cardiac Failure. 10(2). 101–112. 64 indexed citations
5.
Collins, Joseph F., Ronald N. Gaster, W Król, et al.. (2003). A comparison of anterior chamber and posterior chamber intraocular lenses after vitreous presentation during cataract surgery: the Department of Veterans Affairs Cooperative Cataract Study. American Journal of Ophthalmology. 136(1). 1–9. 23 indexed citations
6.
Gottdiener, John S., et al.. (2003). Prevalence of left ventricular thrombus in dilated cardiomyopathy: The WATCH trial. Journal of the American College of Cardiology. 41(6). 202–202. 7 indexed citations
7.
Cramer, Joyce A., Robert A. Rosenheck, Gail Kirk, W Król, & John H. Krystal. (2003). Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes. Value in Health. 6(5). 566–573. 164 indexed citations
8.
Krystal, John, Joyce A. Cramer, W Król, Gail F. Kirk, & Robert A. Rosenheck. (2001). Naltrexone in the Treatment of Alcohol Dependence. New England Journal of Medicine. 345(24). 1734–1739. 432 indexed citations
9.
10.
Massie, B.M., Paul W. Armstrong, John Collins, et al.. (1999). Warfarin and antiplatelet therapy study in chronic heart failure (WATCH): Trial design. Journal of Cardiac Failure. 5(3). 48–48. 3 indexed citations
11.
Williford, William O., W Król, Stephen F. Bingham, Joseph F. Collins, & David G. Weiss. (1995). The Multicenter Clinical Trials Coordinating Center Statistician: “More than a Consultant”. The American Statistician. 49(2). 221–225. 3 indexed citations
12.
Spechler, Stuart J., David Gordon, Jordan Cohen, W. O. Williford, & W Król. (1995). The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.. PubMed. 90(6). 915–8. 22 indexed citations
13.
Williford, William O., W Król, Stephen F. Bingham, Joseph F. Collins, & David G. Weiss. (1995). The Multicenter Clinical Trials Coordinating Center Statistician: "More Than a Consultant". The American Statistician. 49(2). 221–221. 2 indexed citations
14.
Williford, William O., W Król, & Stuart J. Spechler. (1994). Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. Controlled Clinical Trials. 15(5). 335–348. 36 indexed citations
15.
Williford, William O., W Król, & Gordon P. Buzby. (1993). Comparison of eligible randomized patients with two groups of ineligible patients: Can the results of the VA total parenteral nutrition clinical trial be generalized?. Journal of Clinical Epidemiology. 46(9). 1025–1034. 14 indexed citations
16.
Williford, William O., et al.. (1987). The “constant intake rate” assumption in interim recruitment goal methodology for multicenter clinical trials. Journal of Chronic Diseases. 40(4). 297–307. 21 indexed citations
17.
Lowe, G.D.O., et al.. (1985). White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction. Thrombosis and Haemostasis. 54(3). 700–703. 106 indexed citations
18.
Lowe, G.D.O., et al.. (1985). White Cell Count and Recurrent Coronary Events after Myocardial Infarction—An Effect of Myocardial Capillary Plugging?. Clinical Science. 68(s11). 32P–32P. 1 indexed citations
19.
Król, W. (1983). Closing down the study. Controlled Clinical Trials. 4(4). 505–512. 7 indexed citations
20.
Canner, Paul L., W Król, & Sandra Forman. (1983). External quality control programs. Controlled Clinical Trials. 4(4). 441–466. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert R. Karp Breakdown of academic impact, for papers by Michael Gibbs Breakdown of academic impact, for papers by Gary T.C. Ko Breakdown of academic impact, for papers by G. O’Sullivan Breakdown of academic impact, for papers by E. A. M. Gale Breakdown of academic impact, for papers by Minkyung Oh Breakdown of academic impact, for papers by Jingpu Shi Breakdown of academic impact, for papers by Niels Zeuthen Breakdown of academic impact, for papers by Vernice Bates Breakdown of academic impact, for papers by Chien‐Chou Su
Rankless by CCL
2026